Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm

SHJ Hageman, AJ McKay, P Ueda… - European heart …, 2022 - academic.oup.com
Aims The 10-year risk of recurrent atherosclerotic cardiovascular disease (ASCVD) events in
patients with established ASCVD can be estimated with the Secondary Manifestations of …
被引用次数：70 相关文章

Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm

SHJ Hageman, AJ McKay, P Ueda… - EUROPEAN HEART …, 2022 - biblio.ugent.be
Aims The 10-year risk of recurrent atherosclerotic cardiovascular disease (ASCVD) events in
patients with established ASCVD can be estimated with the Secondary Manifestations of …

Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm

SHJ Hageman, AJ McKay, P Ueda… - European heart …, 2022 - pubmed.ncbi.nlm.nih.gov
Aims The 10-year risk of recurrent atherosclerotic cardiovascular disease (ASCVD) events in
patients with established ASCVD can be estimated with the Secondary Manifestations of …

Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: The updated SMART2 algorithm

SHJ Hageman, AJ McKay, P Ueda… - European Heart …, 2022 - discovery.ucl.ac.uk
Aims: The 10-year risk of recurrent atherosclerotic cardiovascular disease (ASCVD) events
in patients with established ASCVD can be estimated with the Secondary Manifestations of …
[PDF] ugent.be

[PDF][PDF] Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm

FLJ Visseren, CR Collaboration - European Heart …, 2022 - backoffice.biblio.ugent.be
Aims The 10-year risk of recurrent atherosclerotic cardiovascular disease (ASCVD) events in
patients with established ASCVD can be estimated with the Secondary Manifestations of …
[HTML] nih.gov

[HTML][HTML] Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm

SHJ Hageman, AJ McKay, P Ueda, LH Gunn… - European Heart …, 2022 - ncbi.nlm.nih.gov
Aims The 10-year risk of recurrent atherosclerotic cardiovascular disease (ASCVD) events in
patients with established ASCVD can be estimated with the Secondary Manifestations of …

[引用][C] Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm

SHJ Hageman, AJ McKay, P Ueda - ascvd-lipidology.knowledgehub …

Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.

SHJ Hageman, AJ McKay, P Ueda, LH Gunn… - European Heart …, 2022 - europepmc.org
Aims The 10-year risk of recurrent atherosclerotic cardiovascular disease (ASCVD) events in
patients with established ASCVD can be estimated with the Secondary Manifestations of …
[PDF] researchgate.net

[PDF][PDF] Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm

FLJ Visseren, CR Collaboration - 2022 - researchgate.net
Aims The 10-year risk of recurrent atherosclerotic cardiovascular disease (ASCVD) events in
patients with established ASCVD can be estimated with the Secondary Manifestations of …

Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.

SHJ Hageman, AJ McKay, P Ueda, LH Gunn… - 2022 - cabidigitallibrary.org
Aims: The 10-year risk of recurrent atherosclerotic cardiovascular disease (ASCVD) events
in patients with established ASCVD can be estimated with the Secondary Manifestations of …